Probiotics in Pediatric Gastroenterology: Emerging Indications: Inflammatory Bowel Diseases

Journal of Clinical Gastroenterology

Volumn 52, Issue , 2018, Pages S7-S9

  Scarpato, Elena ^a   Russo, Marina ^a   Staiano, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

bacterial strains; children; Crohn's disease; intestinal microbiota; ulcerative colitis

Indexed keywords

PROBIOTIC AGENT; VSL3;

ARTICLE; BACTERIAL STRAIN; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LACTOBACILLUS REUTERI; NONHUMAN; PATHOGENESIS; PEDIATRICS; PRIORITY JOURNAL; TREATMENT INDICATION; ULCERATIVE COLITIS; CHILD; CROHN DISEASE; GASTROENTEROLOGY; MICROBIOLOGY; PROCEDURES; REMISSION;

CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; GASTROENTEROLOGY; GASTROINTESTINAL MICROBIOME; HUMANS; LACTOBACILLUS REUTERI; PEDIATRICS; PROBIOTICS; REMISSION INDUCTION;

EID: 85051086970     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000001095     Document Type: Article

References (20)

1. Larmonier CB, Shehab KW, Ghishan FK, et al. T lymphocyte dynamics in inflammatory bowel diseases: role of the microbiome. Biomed Res Int. 2015;2015:504638.
2. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-594.
3. Albenberg LG, Wu G. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology. 2014;146:1564-1572.
4. D'Argenio V, Precone V, Casaburi G, et al. An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy. Am J Gastroenterol. 2013;108:851-852.
5. Steck N, Hoffmann M, Sava IG, et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology. 2011;141: 959-971.
6. Kim YG, Park JH, Reimer T, et al. Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host Microbe. 2011;9:496-507.
7. Li Q, Wang C, Tang C, et al. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J Clin Gastroenterol. 2014;48:513-523.
8. Jonkers D, Penders J, Masclee A, et al. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs. 2012; 72:803-823.
9. Suskind DL, Cohen SA, Brittnacher MJ, et al. Clinical and fecal microbial changes with diet therapy in active inflammatory bowel disease. J Clin Gastroenterol. 2018;52:155-163.
10. Gosiewski T, Strus M, Fyderek K, et al. Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2012;54:20-27.
11. Gevers D, Kugathasan S, Denson LA, et al. The treatmentnaive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15:382-392.
12. Guandalini S. Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Expert Rev Clin Immunol. 2010;6:47-54.
13. Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2010;7:503-514.
14. Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014;20:21-35.
15. Bousvaros A, Guandalini S, Baldassano RN, et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis. 2005;11:833-839.
16. Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis. 2014;8:1179-1207.
17. Miele E, Shamir R, Aloi M, et al. Nutrition in pediatric inflammatory bowel disease: a position paper on behalf of the porto inflammatory bowel disease group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66:687-708.
18. Miele E, Pascarella F, Giannetti E, et al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. 2009;104:437-443.
19. Oliva S, Di Nardo G, Ferrari F, et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther. 2012;35:327-334.
20. Turner D, Levine A, Escher JC, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr. 2012;55:340-361.